Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1
- PMID: 11790771
- DOI: 10.1074/jbc.M108252200
Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1
Abstract
Human aurora A is a serine-threonine kinase that controls various mitotic events. The transcription of aurora A mRNA varies throughout the cell cycle and peaks during G(2)/M. To clarify the transcriptional mechanism, we first cloned the 1.8-kb 5'-flanking region of aurora A including the first exon. Transient expression of aurora A promoter-luciferase constructs containing a series of 5'-truncated sequences or site-directed mutations identified a 7-bp sequence (CTTCCGG) from -85 to -79 as a positive regulatory element. Electromobility shift assays identified the binding of positive regulatory proteins to the CTTCCGG element. Anti-E4TF1-60 antibody generated a supershifted complex. Furthermore, coexpression of E4TF1-60 and E4TF1-53 markedly increased aurora A promoter activity. Synchronized cells transfected with the aurora A promoter-luciferase constructs revealed that the promoter activity of aurora A increased in the S phase and peaked at G(2)/M. In addition, we identified a tandem repressor element, CDE/CHR, just downstream of the CTTCCGG element, and mutation within this element led to a loss of cell cycle regulation. We conclude that the transcription of aurora A is positively regulated by E4TF1, a ubiquitously expressed ETS family protein, and that the CDE/CHR element was essential for the G(2)/M-specific transcription of aurora A.
Similar articles
-
Cell cycle-dependent regulation of the human aurora B promoter.Biochem Biophys Res Commun. 2004 Apr 9;316(3):930-6. doi: 10.1016/j.bbrc.2004.01.178. Biochem Biophys Res Commun. 2004. PMID: 15033491
-
Characterization of the human thrombopoietin gene promoter. A possible role of an Ets transcription factor, E4TF1/GABP.J Biol Chem. 1997 Apr 25;272(17):11361-8. doi: 10.1074/jbc.272.17.11361. J Biol Chem. 1997. PMID: 9111044
-
Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.Gene. 2005 Nov 21;361:89-100. doi: 10.1016/j.gene.2005.07.012. Epub 2005 Sep 21. Gene. 2005. PMID: 16181749
-
Cell cycle regulation of the human polo-like kinase (PLK) promoter.J Biol Chem. 1997 Apr 4;272(14):9166-74. doi: 10.1074/jbc.272.14.9166. J Biol Chem. 1997. PMID: 9083047
-
Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells.Biochem Biophys Res Commun. 2001 Nov 30;289(2):491-8. doi: 10.1006/bbrc.2001.5993. Biochem Biophys Res Commun. 2001. PMID: 11716500
Cited by
-
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.Front Oncol. 2022 Oct 27;12:1026020. doi: 10.3389/fonc.2022.1026020. eCollection 2022. Front Oncol. 2022. PMID: 36387232 Free PMC article. Review.
-
Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer.Cancers (Basel). 2021 May 28;13(11):2659. doi: 10.3390/cancers13112659. Cancers (Basel). 2021. PMID: 34071321 Free PMC article. Review.
-
Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.Neoplasia. 2008 Aug;10(8):828-37. doi: 10.1593/neo.08408. Neoplasia. 2008. PMID: 18670641 Free PMC article.
-
A new aurora in anaplastic thyroid cancer therapy.Int J Endocrinol. 2014;2014:816430. doi: 10.1155/2014/816430. Epub 2014 Jul 1. Int J Endocrinol. 2014. PMID: 25097550 Free PMC article. Review.
-
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy.Mol Cancer. 2021 Jan 15;20(1):15. doi: 10.1186/s12943-020-01305-3. Mol Cancer. 2021. PMID: 33451333 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases